RPS6KA3 and breast cancer: Our meta-analysis demonstrated that RSK2 expression in breast cancer tissue was lower than that in normal tissue (pooled OR = 0.54, 95% CI: 0.44–0.67, Cochran’s Q test p = 0.14, I2 = 41.7%) (Figure 2A).